Journals / Erciyes Medical Journal / 2021 / Cilt: 43 - Sayı: 6

Evaluation of Performance Between Thoracic Computed Tomography and Reverse TranscriptionPolymerase Chain Reaction Test in Coronavirus Disease-19 Management

Pages
594–599
Publication Date
2022-10-11
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

The assessment of thoracic CT in accordance with the RSNA criteria can be considered a convenient approach for clinicians in the emergency department when deciding on hospitalization or discharge.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: In the present study, we compare Computed Tomography (CT) findings reported according to the Radiology Society of North America (RSNA) criteria and reverse transcription-polymerase chain reaction (RT-PCR) test results to evaluate their clinical compatibility with the diagnosis and for making the decision on hospitalization or discharge in patients presenting to the emergency department with the suspected Coronavirus disease (COVID)-19.
📊
Key Findings & Data:Over the age of 18 years, patients were included, pregnant and trauma patients were excluded from the study.
💡
Conclusion & Impact:The assessment of thoracic CT in accordance with the RSNA criteria can be considered a convenient approach for clinicians in the emergency department when deciding on hospitalization or discharge.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Objective: In the present study, we compare Computed Tomography (CT) findings reported according to the Radiology Society of North America (RSNA) criteria and reverse transcription-polymerase chain reaction (RT-PCR) test results to evaluate their clinical compatibility with the diagnosis and for making the decision on hospitalization or discharge in patients presenting to the emergency department with the suspected Coronavirus disease (COVID)-19. Materials and Methods: This is retrospective single-center study. Over the age of 18 years, patients were included, pregnant and trauma patients were excluded from the study. The patients’ demographic characteristics, and their RT-PCR test, thoracic CT images results, and outcomes were recorded. Results: Our study was conducted with 1377 patients, of which 60.2% (n=829) were male with a mean age of 42.79±16.07 (13–95) years. The sensitivity and specificity of the thoracic CT and RT-PCR test in diagnosis were, based on the first and second test results, the sensitivity was 63.34% (95% confidence interval [CI], 0.586–0.679) and the specificity was 81.08% (95% CI, 0.784–0835) for CT, and the sensitivity was 71.93% (95% CI, 0.674–0.761) for RT-PCR. Thoracic CT incompatible with COVID-19 and discharged 63.7% of patients did not apply to other healthcare facilities with COVID-19 symptoms. Conclusion: The most effective approach to early diagnosis and the initiation of treatment is still the patient’s clinical picture and thoracic CT findings, as seen in the present study. The assessment of thoracic CT in accordance with the RSNA criteria can be considered a convenient approach for clinicians in the emergency department when deciding on hospitalization or discharge.

🔖

Cite This Article

KARAKAYA, Z., KARAALİ, R., BORA, E. S., AKYOL, P. Y., BİLGİN, S. (2022). Evaluation of Performance Between Thoracic Computed Tomography and Reverse TranscriptionPolymerase Chain Reaction Test in Coronavirus Disease-19 Management. Erciyes Medical Journal, Cilt: 43 - Sayı: 6, 594–599. https://ajindex.com/articles/502292

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (13)

  1. World Health Organization. Coronavirus disease 2019 (COVID-19) situation report, No
  2. Geneva: World Health Organization; 2019. Available from: https://www.who.int/docs/default-source/coronaviruse/situation-reports. Accessed July 23, 2020
  3. Yates TA, Cooke GS, MacPherson P. Rational use of SARS-CoV-2 polymerase chain reaction tests within institutions caring for the vulnerable. F1000Res 2020; 9: 671
  4. Li Y, Yao L, Li J, Chen L, Song Y, Cai Z, et al. Stability issues of RT-PCR testing of SARS-CoV-2 for hospitalized patients clinically diagnosed with COVID-19. J Med Virol 2020; 92(7): 903–8
  5. Fang Y, Zhang H, Xie J, Lin M, Ying L, Pang P, et al. Sensitivity of Chest CT for COVID-19: Comparison to RT-PCR. Radiology 2020; 296(2): E115–7
  6. Cengel F, Gurkan O, Calik M, Demirkol MA, Altunok ES, Kaya MF, et al. Diagnosis of the coronavirus disease 2019 with chest computed tomography: A retrospective inter-observer agreement study between radiologists and clinicians. Hong Kong J Emerg Med 2020; 28(1): 1–7.
  7. Xu X, Yu C, Qu J, Zhang L, Jiang S, Huang D, et al. Imaging and clinical features of patients with 2019 novel coronavirus SARS-CoV-2. Eur J Nucl Med Mol Imaging 2020; 47(5): 1275–80
  8. Li Y, Xia L. Coronavirus disease 2019 (COVID-19): Role of chest CT in diagnosis and management. AJR Am J Roentgenol 2020; 214(6): 1280–6
  9. Chung M, Bernheim A, Mei X, Zhang N, Huang M, Zeng X, et al. CT imaging features of 2019 novel coronavirus (2019-nCoV). Radiology 2020; 295(1): 202–7
  10. Li B, Li X, Wang Y, Han Y, Wang Y, Wang C, et al. Diagnostic value and key features of computed tomography in coronavirus disease 2019. Emerg Microbes Infect 2020; 9(1): 787–93
  11. Simpson S, Kay FU, Abbara S, Bhalla S, Chung JH, Chung M, et al. Radiological society of North America expert consensus statement on reporting chest CT findings related to COVID-19. Endorsed by the society of thoracic radiology, the American College of Radiology, and RSNA. Radiology 2020; 2(2): 2020200152
  12. Abbasi-Oshaghi E, Mirzaei F, Farahani F, Khodadadi I, Tayebinia H. Diagnosis and treatment of coronavirus disease 2019 (COVID-19): Laboratory, PCR, and chest CT imaging findings. Int J Surg 2020; 79: 143–53
  13. He JL, Luo L, Luo ZD, Lyu JX, Ng MY, Shen XP, et al. Diagnostic performance between CT and initial real-time RT-PCR for clinically suspected 2019 coronavirus disease (COVID-19) patients outside Wuhan, China. Respir Med 2020; 168: 105980. 13.